Huarong (Guangdong) Pharmaceutical Co., Ltd. (established in 2023) is a powerful enterprise integrating scientific research, production and supply, and has in-depth cooperation with Lao United Pharmaceutical. The company has an exclusive R&D team, its own production park and two production bases in Guangzhou Huangpu and Shaoguan Nanxiong, covering a total area of 80 acres, a construction area of more than 30,000 square meters, more than 100 employees, and a total investment of 200 million yuan. Focusing on the R&D and mass production of amino acids and peptides, with an annual production capacity of 4,000 tons and an estimated annual output value of 1 billion yuan, it is a leading intelligent biosynthetic API production base in China to ensure quality with full-process quality control and serve customers in many countries around the world. The company has two R&D centers in Guangdong and Jiangxi, and has established in-depth cooperative relations with Hunan University, South China Agricultural University, Nanchang University, Liaocheng University, Jiangxi University of Traditional Chinese Medicine and other universities. At present, it has built a complete experimental platform such as synthesis laboratory, microbiology laboratory, fermentation laboratory, and quality analysis laboratory, and is equipped with an exclusive technology center responsible for technology transformation and large-scale production. The R&D team has strong strength, and now has 3 senior engineers, 5 personnel with master's degree or above, and 20 personnel with bachelor's degree or above. The laboratory is equipped with various advanced synthesis, biological and testing equipment, including 5 HPLC chromatographs, 2 gas chromatographs, 1 gram-level preparative chromatograph, 1 100-gram preparative chromatograph, 1 peptide solid-phase synthesizer, 3 5-liter fermenters, 3 100-liter fermenters, 3 biological safety cabinets, 3 oscillating incubators, 1 freeze dryer, etc.